The purpose of this study is to compare the usual radiation therapy and usual chemotherapy, temozolomide, to using the usual radiation therapy and usual chemotherapy plus the chemotherapy drug lomustine (Gleostine) to treat MGMT methylated glioblastoma brain tumors.
Learn more about the NRG-BN011 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
